Many questions about the regulation, functional specialization, computational prediction, and evolution of genomic imprinting would be better addressed by having an exhaustive genome-wide catalog of genes that display parent-of-origin differential expression. As a first-pass scan for novel imprinted genes, we performed mRNA-seq experiments on E17.5 mouse placenta cDNA samples from reciprocal cross F1 progeny of AKR and PWD mouse strains, and quantified the allelespecific expression and the degree of parent-of-origin allelic imbalance. We confirmed the imprinting status of 23 known imprinted genes in the placenta, and found that 12 genes reported previously to be imprinted in other tissues are also imprinted in mouse placenta. Through a wellreplicated design using an orthogonal allelic-expression technology, we verified five novel imprinted genes that were not previously known to be imprinted in mouse (Pde10, Phf17, Phactr2, Zfp64 and Htra3). Our data suggest that most of the strongly imprinted genes have already been identified, at least in the placenta, and that evidence supports perhaps 100 additional weakly imprinted genes. Despite previous appearance that the placenta tends to display an excess of maternally-expressed imprinted genes, with the addition of our validated set of placenta-imprinted genes, this maternal bias has disappeared. 4
INTRODUCTION
Genomic imprinting occurs when the expression of the maternal and paternal copies of a gene differ in a parent-of-origin dependent manner (REIK and WALTER 2001) . Several mechanisms of genomic imprinting are shared by higher plants and therian mammals, involving differential DNA methylation, non-coding RNA and/or histone modifications (DELAVAL and FEIL 2004; HUDSON et al. 2010; PAULER and BARLOW 2006) , although imprinting almost certainly arose independently in these lineages. Imprinted genes are often expressed and imprinted in a tissue-and developmental stage-specific manner. Although known imprinted genes tend to be clustered in the genome, there has been an ascertainment bias in concentrating the search among nearby genes for new imprinted candidates, motivating a need for a more balanced genome-wide scan. The occurrence of medical disorders associated with defects in imprinting provides further motivation to produce an exhaustive identification of imprinted genes. Because one allele is virtually silenced, mutations transmitted from the expressing parent behave in a dominant fashion, as is seen in human disorders associated with defects in imprinted genes (BUTLER 2009; JIANG et al. 2004 ).
To date, more than 100 imprinted genes have been discovered in the mouse (MORISON et al. 2005) , but the list is not exhaustive. Transcriptome-wide and genome-wide attempts to search for novel imprinted genes have exploited different approaches (HENCKEL and ARNAUD 2010; MAEDA and HAYASHIZAKI 2006) . Genome-wide bioinformatic predictions have successfully identified novel imprinted genes in human and mouse (BRIDEAU et al. 2010; LUEDI et al. 2007; LUEDI et al. 2005; YANG et al. 2003) , but the prediction power is low because the training set of known imprinted genes is small, and the genomic clustering of imprinted genes violates independence of the imprinting signals (DAELEMANS et al. 2010) . Earlier experimental approaches such as expression microarrays on parthenogenetic and androgenetic embryos (KUZMIN et al. 2008; MIZUNO et al. 2002; SRITANAUDOMCHAI et al. 2010) , expression arrays on uniparental disomic (UPD) mice (CHOI et al. 2001; CHOI et al. 2005; SCHULZ et al. 2006) , and allele-specific expression arrays on individuals with informative SNPs (BRIDEAU et al. 2010; POLLARD et al. 2008 ) have identified many novel imprinted genes on a larger scale than the single-gene approach. However, these methods require an abnormal configuration of the genome and can only cover a subset of genes included in the array design or the UPD region. DNA methylation-based methods have successfully identified a number of novel imprinted genes (PETERS et al. 1999; SMITH et al. 2003) .
This method first searches for differentially methylated regions (DMR), then examines the genes in close proximity to each novel DMR. Since not all imprinted genes have an associated DMR, even this approach will likely miss some novel imprinted genes. To overcome these problems and begin to identify imprinted genes transcriptome-wide in a variety of tissues, we ) and other investigators (BABAK et al. 2008; GREGG et al. 2010a; GREGG et al. 2010b ) have carried out mRNA-seq studies to identify novel imprinted genes through differential allele-specific expression in reciprocal F1 plants and animals. Wang et al. and Babak et al. are the first studies using RNA-seq of mouse reciprocal crosses to search for novel imprinted genes. Wang et al. performed RNA-seq of mouse neonatal day 2 (P2) brains from reciprocal crosses of AKR and PWD strains. We discovered and confirmed 14 known and 3 novel imprinted genes in P2 brains. Babak et al. did transcriptome sequencing on embryonic day 9.5 (E9.5) embryos in CAST/EiJ and C57BL/6J reciprocal crosses and they found 14 imprinted genes which are all known in mouse. No novel imprinted genes emerged from this study. Recently, Gregg et al. published an RNA-seq study on embryonic and adult brains of CAST/EiJ and C57BL/6J reciprocal crosses. Whole E15 brain, adult cortex, and adult hypothalamus samples were sequenced and analyzed, and they claimed more than 1,300 genes showed differential parental allelic expression in the brain. It is clear that RNA-seq provides a powerful tool for scoring parent-of-origin differential expression, and that differences in targeted tissue, developmental stage, sequence quantity, methods of validation may contribute to differences across these studies.
In the mouse, most of the known imprinted genes are expressed and imprinted in the brain and/or placenta (MORISON et al. 2005) . The placenta is a mammalian-specific organ, which has important nutritional transport and immune functions for fetal growth. The placenta has been a primary target organ in studies of genomic imprinting in terms of the number and importance of known imprinted genes (FROST and MOORE 2010; WAGSCHAL and FEIL 2006) , motivating this RNA-seq analysis of reciprocal F1 mice to discover novel imprinted genes. Since all three previous transcriptome-wide RNA-seq studies were focused on brain or embryonic tissue, our first-pass survey in mouse placenta will complement previous studies and provide information on a tissue of particularly focused interest to the imprinting community.
MATERIALS AND METHODS

Mouse Strains and crosses:
The four mouse strains (AKR/J, PWD/PhJ, C57BL/6 and CAST/EiJ) and the two reciprocal crosses with two strain combinations (PWD/PhJ x AKR/J, AKR/J x PWD/PhJ and C57BL/6 x CAST/EiJ, CAST/EiJ x C57BL/6) were described in (WANG et al. 2010) . We dissected E17.5 placenta tissues from the F1 mice from the following crosses: AKR/J female x PWD/PhJ male cross (AKR x PWD for short), PWD/PhJ female x AKR/J male (PWD x AKR for short), C57BL/6 female x CAST/EiJ male (B6 x CAST for short), and CAST/EiJ female x C57BL/6 male (CAST x B6 for short). To minimize maternal contamination, we cut only the fetal side of the placenta tissue during dissection. E17.5 was chosen because it is late enough to be able to get enough tissue in these dissections, but early enough to make it fairly easy to avoid maternal contamination.
We extracted total RNA samples from the placentas harboring the F1 progeny using Qiagen RNeasy Plus Mini Kit (Qiagen, CA). The RNA concentrations and A260 nm/A280 nm ratios were quantified with a NanoDrop ND-1000 Spectrophotometer (Thermo Scientific, DE). RNA integrity was tested using the Agilent 2100 Bioanalyzer (Agilent Technologies, Inc, CA). All of the samples had a RIN (RNA integrity number) in the range 9.6-10.0 (RIN max = 10.0). AKR/J and PWD/PhJ genomic DNA were purchased from the Jackson Laboratory (www.jax.org).
Illumina mRNA sequencing of the F1 placenta transcriptome: Our initial mRNA-seq was performed on total RNA samples from one AKR female x PWD male and one PWD female x AKR male placenta using an Illumina Genome Analyzer (Illumina Inc., CA). The mRNA-seq libraries were made with 5 µg of starting total RNA samples using the mRNA-Seq 8-Sample Prep Kit (Illumina Inc., CA), following the Illumina protocol for mRNA sequencing sample preparation.
Eight Illumina GA lanes were sequenced for the AKR x PWD library and seven lanes for the PWD x AKR library. Image analysis and base calling were performed by the Illumina instrument software. In total, our initial screen consisted of 66.0 million short reads (read length 44 bp) for the AKR x PWD cross, and 63.3 million reads for the PWD x AKR cross. mRNA-seq Alignment and quantification of total and allele-specific expression: The reads were truncated to 40 bp and aligned to the mouse reference genome (NCBI B37) using BWA with a maximum of four mismatches (LI and DURBIN 2009 ). On average, 55.2% of the reads were mapped uniquely to the reference genome. Alignment counts in the exon regions were summarized by custom scripts. To identify reads that mapped to the exon-intron junctions, we built a junction database by extracting all possible junction sequences, based on the gene and exon models from the Ensembl database (www.ensembl.org). 4.8% of the total reads were mapped to the exon-intron junctions. The exon and junction counts were normalized by the transcript length and the total number of mapped reads to compute RPKM (MORTAZAVI et al. 2008) . We covered 12,532 unique Ensembl genes (41,110 Ensembl transcripts) with RPKM ≥ 1. If we use a more stringent cut-off of RPKM ≥ 5, then 6,794 unique genes (20,026 transcripts) are retained.
To quantify the allele-specific expression in the two reciprocal crosses, at each identified SNP position we counted the reads with the reference allele as well as reads with the alternative allele . In addition to using the known sequence differences between the mouse strains used, we also performed de novo SNP calling from the uniquely aligned reads using SAMtools software ), followed by our own post-filtering scripts. To determine the transmission direction, we used the AKR/J allele information from the Sanger mouse genome project 2010-03 SNP release (http://www.sanger.ac.uk/resources/mouse/genomes/). Since there is imprinted X inactivation in the mouse placenta (HUYNH and LEE 2005; SADO and FERGUSON-SMITH 2005) , SNPs with an X-chromosome homolog will mistakenly suggest a maternally-expressed imprinted gene. To eliminate this bias, we BLATed all SNPs with sequence from 50 bp upstream and 50 bp downstream to the genome (http://genome.ucsc.edu/cgi-bin/hgBlat?command=start). We removed all SNPs with an X chromosome BLAT hit that matched with length 40 or more (equal to the read length).
In total, 43,510 high quality autosomal SNPs with 4 or more counts in each of the two reciprocal crosses were identified. 41,953 SNPs (96.4%) are within 1 kb upstream or downstream of Ensembl gene models. Manual annotation was performed for three known imprinted genes that are not in the Ensembl database (Peg10, Rian, Mirg). Because both the AKR and PWD alleles in the F1 transcriptome are mapped to the reference genome, which was assembled from the B6 strain, there will be genome mapping bias toward the AKR allele if we use the same cut-off for both alleles (AKR is closer to B6 than it is to the PWD strain in terms of genetic distance). To remove this mapping bias, we generated a pseudo-genome, by replacing the reference allele in the genome with the alternative allele. Then we redid the alignment with the same cut-off to the pseudo-genome. We used the averaged counts from the reference genome and pseudo-genome as the final SNP count summary.
Detection of significant parent-of-origin effects and identification of candidate imprinted genes: To select candidate imprinted genes for verification, we applied a formal statistical test to the 2 x 2 contingency table formed by the tally of reads of the two alleles in the two reciprocal crosses . In addition to using this statistical significance, we also filtered the results based on the magnitude of the allelic expression bias. We define p 1 as the AKR allele percentage in the AKR x PWD cross and p 2 as the AKR allele percentage in the PWD x AKR cross.
For a 100% maternally expressed candidate imprinted gene, we expect p 1 = 1 and p 2 = 0. For partially imprinted genes with preferential maternal expression, we used a cut-off of p 1 > 0.65 and p 2 < 0.35 (and similarly, we selected the paternally expressed imprinted candidates with a cut-off of p 1 < 0.35 and p 2 > 0.65). This cut-off is somewhat arbitrary and was meant to avoid the inclusion of genes with a weak allelic imbalance that would otherwise be included in our imprinted candidate set only because they are so highly expressed that they become statistically significant. For graphical presentation and discussion, the metric p 2 -p 1 quantifies the parent-of-origin effect in the range from -1 to +1. If there is no parent-of-origin effect, then p 2 -p 1 = 0. If there is preferential expression of the paternal allele, then p 2 -p 1 > 0. If there is preferential expression of the maternal allele, then p 2 -p 1 < 0. In order to keep the false positive rate low, we only include candidate genes with two or more informative SNPs. Verification of the candidate imprinted genes with allele-specific pyrosequencing: We selected three known imprinted genes (Igf2, Peg10 and Klf14) and seven candidate imprinted genes (Pde10a, Phf17, Gpsm2, Zfp64, Htra3, Phactr2 and Trim23) for allele-specific expression quantification using Pyrosequencing. To exclude the possibility of stochastic expression effects and sex-specific genomic imprinting, we verified these genes in placentas harboring 3 female and 1 male F1 progeny from each of AKR-PWD reciprocal crosses. To exclude strain-specific effects, we verified three novel imprinted genes (Pde10a, Phf17 and Phactr2) in an additional 3 female and 1 male progeny bearing placentas from each of B6-CAST reciprocal crosses. The pyrosequencing assay design and sequencing protocol can be found in (WANG et al. 2010) .
RESULTS
mRNA-seq alignments, transcriptome coverage and SNP calling: This mRNA-seq study was performed on E17.5 placental tissues from reciprocal crosses of AKR and PWD mouse strains.
We obtained 66 million 44-bp reads from placenta cDNA of a single AKR x PWD F1 individual and 63 million reads from the reciprocal PWD x AKR placental transcriptome. 60% of the reads could be uniquely mapped to the NCBI B37 mouse reference genome, with 55.2% of reads mapping to the exons and 4.8% mapping to the exon-intron junctions. The total expression levels were quantified by RPKM, which is a normalized per gene read counts (MORTAZAVI et al. 2008 ). In the RNA-seq data, there was coverage of 12,532 Ensembl unique genes (41,110 transcripts) with RPKM greater than 1, and 6,794 unique genes had an RPKM value greater than 5.
Informative SNP positions are needed to quantify the allele-specific expression. From de novo SNP calling based on the RNA-seq data, after quality filtering, we found 43,510 high-quality autosomal SNPs, 96.4% of which reside in known Ensembl gene models. To remove the genome mapping bias, we summarized the SNP counts by the average count when mapped to the reference genome and to a pseudo-genome of the alternate strain (See Materials and Methods).
Detection of significant parent-of-origin effects:
From the read counts at the informative SNP positions, we were able to determine the allele-specific expression ratio from the relative counts of the reference and alternative alleles . We define p 1 as the expression percentage from the AKR allele in placentas from the AKR female x PWD male cross and p 2 as the AKR allele percentage in the reciprocal cross. In regard to the direction of transmission, p 1 is the maternal allele percentage in AKR x PWD, and p 2 is the paternal percentage for PWD x AKR. The Storer-Kim test was used as a formal statistical test of the null hypothesis that (p 2 -p 1 ) = 0.
Rejections of this null hypothesis identify novel imprinted candidate genes (See Materials and
Methods). To further filter the data and reduce false positives, rather than relying only on the Pvalue of the Storer-Kim test, we also used an arbitrary cut-off of p 1 > 0.65 and p 2 < 0.35 for maternally expressed candidates, and p 1 < 0.35 and p 2 > 0.65 for paternally expressed ones. This allows for identification of partially imprinted genes when there are sufficiently many reads spanning the SNPs to make a confident call.
Out of the 5,557 unique genes covered with two or more informative SNPs, with the above criteria for significant parent-of-origin effect identification, we found 251 significant candidates with qvalue < 0.01 and SNP coverage 4 or more in each of the two reciprocal crosses (criterion 1). Of these candidate genes, 120 have preferential maternal expression, and 131 have a paternally biased expression (Table S1 ). If we use RPKM>1 and SNP coverage>10 in both reciprocal crosses as the criteria for inclusion, 216 significant candidates are left, with 115 paternal and 101 maternal candidates (criterion 2). If we use a more stringent cut-off of PRKM>3 and SNP coverage>20, only 113 candidates are retained, with 60 paternal and 53 maternal candidates (criterion 3). To visualize the allelic expression ratio and the degree of parent-or-origin effect genome-wide, we made a plot for each autosome ( Figure S1 ), and chromosome 7 is shown in Figure 1 as an example. From these figures, we observed that most of the genes show nearly 50:50 allelic expression ratios, when we scan along the chromosomes. A number of significant candidate imprinted genes emerged from the parent-of-origin effect plot.
Significant candidate imprinted genes that are previously known to be imprinted in mouse: Among the 251 candidate imprinted genes that we identified from criterion 1, 35 have been previously reported in the mouse literature to be imprinted. For each gene, the number of SNPs, total SNP counts, allelic expression ratios and the q-value are summarized in Table 1 . We compared the expression direction of these genes in our RNA-seq data and the previously reported imprinting direction, and 35 out of 35 matched. 23 of the 35 genes were known to be imprinted in mouse placenta in various stages and crosses: Igf2 (DECHIARA et al. 1991; HU et al. 1995) , Peg10 (ONO et al. 2003 ), Sfmbt2 (KUZMIN et al. 2008 , Sgce (PIRAS et al. 2000) , Plagl1 (PIRAS et al. 2000; SMITH et al. 2002 ), Slc38a4 (MIZUNO et al. 2002 SMITH et al. 2003) , Airn (also known as Igf2rAS) (WUTZ et al. 1997 ) , Rtl1 (SEITZ et al. 2003 , Mest (KANEKO-ISHINO et al. 1995) , Igf2as (MOORE et al. 1997) and Dlk1 (SCHMIDT et al. 2000) are known to be paternally expressed in the mouse placenta;
H19 (BARTOLOMEI et al. 1991 ), Igf2r (BARLOW et al. 1991 ), Cdkn1c (HATADA and MUKAI 1995 , Kcnq1(GOULD and PFEIFER 1998) are preferentially expressed from the maternal allele. The remaining 12 genes are either known to be not imprinted in the placenta or the imprinting status in the placenta is not clear. In this study, we found that they are actually imprinted in E17.5 mouse placenta in AKR-PWD reciprocal crosses. Peg3 (KANEKO-ISHINO et al. 1995 ) is known to be imprinted in the human placenta (HIBY et al. 2001) , however, the imprinting status in the mouse placenta had not been reported. Ndn (MACDONALD and WEVRICK 1997) and Magel2 (BOCCACCIO et al. 1999) are both expressed in the mouse placenta, whereas the imprinting status was not clear. Rian (HATADA et al. 2001) 
Nnat (KAGITANI et al. 1997 ), Zdbf2 (KOBAYASHI et al. 2009 ) and Zrsr1 (HATADA et al. 1993) were not previously reported to be imprinted in the mouse placenta either. Therefore, we identified 12 candidate genes with novel mouse placenta imprinting status.
The q-value rank order is presented in Table 1 . We noticed that most of the known imprinted genes identified in our study have higher q-value rank relative to other genes, most of them are highly expressed in the placenta, and the imprinting status of most previously known imprinted genes is close to 100%. We conclude that most of the significant imprinted genes with highest degree of parent-of-origin bias have already been identified by the genomic imprinting community.
The high concordance (35 out of 35) of known imprinted genes with the significance of our test of parent-of-origin effects on allelic expression ratios provides one measure of the confidence in the results despite the lack of replication at the RNA-seq stage.
Identification and verification of novel imprinted genes in the mouse placenta:
To confirm the novel imprinted candidates identified above, we need to quantify their allele-specific expression using an independent method. We performed pyrosequencing to quantify allele-specific expression in two reciprocal F1 placenta samples. Pyrosequencing is a highly quantitative method to profile the allelic expression ratio, with a measurement coefficient of variation of 2-5% (MARSH 2007) . To exclude the possibility of random monoallelic expression for specific genes (GIMELBRANT et al. 2007; LOMVARDAS et al. 2006) , and potential sex-specific imprinting status (GREGG et al. 2010a) , we verified the candidates in 4 AKR x PWD F1 individuals (3 females and 1 male) and 4 PWD x AKR F1 individuals (3 females and 1 male). The average allelic percentage is reported in Table 2 .
We selected a total of ten candidate genes for verification, including three known imprinted genes as positive controls (Igf2, Peg10 and Klf14). Among the top 20 candidates, only 2 are novel (Pde10a and Phf17), and we included both. Then we selected five additional novel candidates (Gpsm2, Zfp64, Htra3, Trim23 and Phactr2) for verification.
From the pyrosequencing results in Table 2 , eight of the ten known and novel candidate genes we tested are verified to be imprinted; one candidate gene (Trim23) did not show good pyrosequencing signal due to low expression level; we observed biallelic expression for one candidate gene (Gspm2). Further examination of the Gspm2 gene region reveals that the different SNPs are not consistent in RNA-seq data. Careful inspection of the RNA-seq read alignments suggests that the false-positive call may have been made because of poor read mapping, as the read depth is unusually variable around this gene. Therefore, we have an empirical false discovery rate of 1 out of 9 or 11% confirmed by our pyrosequencing verification results.
Igf2 and Peg10 were correctly verified as paternally expressed imprinted genes, and Klf14 as maternally expressed imprinting gene, which is consistent with the results in our RNA-seq data.
Among the seven novel candidates, five (Pde10a, Phf17, Zfp64, Htra3 and Phactr2) were verified to be novel imprinted genes in the mouse placenta (Table 2) , one test failed due to low expression, and one failed to validate.
Pde10a is the most significant novel candidate gene (q-value rank 15). It is located on chromosome 17, 3.6 Mbp away from the known imprinted gene, Slc22a3. It is a member of the phosphohydrolyase gene family, catalyzing the hydrolysis of the cAMP and cGMP to the respective nucleoside 5' monophosphate (LOUGHNEY et al. 1999; SODERLING et al. 1999) . Pyrosequencing primers were designed to target one of the 12 significant SNPs in this gene (Figure 2A ). In the RNA-seq data, we observed expression primarily from the maternal allele in both AKR x PWD and PWD x AKR reciprocal crosses ( Figure 2B ). We verified it in four placentas from each of the two reciprocal crosses, and we found consistent preferential maternal expression. To exclude the possibility of strain-specific imprinting, we also tested placenta tissue from B6-CAST reciprocal crosses, and we obtained the same results (Table S2) . Thus, we conclude that Pde10a is a novel imprinted gene in the E17.5 mouse placenta.
Phf17 is the second most significant novel candidate in the list. It is located on mouse chromosome 4 and it is not near any of the known imprinting cluster. Phf17 (aka Jade1) is a component of the HBO1 complex which has a histone H4-specific acetyltransferase activity and performs most of the histone H4 acetylation in vivo (FOY et al. 2008) . Imprinted genes involved in histone modifications are particularly interesting, as they may provide a means for amplification of the imprinting signal, and for propagating the effect to other target genes. Pyrosequencing verifications confirmed preferential paternal expression in both AKR-PWD and B6-CAST crosses (Table 2 and Table S2 ).
Phactr2 is a phosphatase and actin regulator, and it is identified in our RNA-seq study as a maternally expressed imprinted candidate. This gene had not previously been known to be imprinted in mouse. We verified it in multiple individuals of both AKR-PWD and B6-CAST crosses, and it is confirmed to be preferentially expressed from the maternal allele (Table 2 and   Table S2 ). In a recent Illumina ASE BeadArray survey of novel imprinted genes in human term placenta, human PHACTR2 is found to be partially imprinted, with a maternal allelic bias (DAELEMANS et al. 2010) . Therefore, the imprinting status of Phactr2 is conserved between mouse and human. Phactr2 is on mouse chromosome 10, 104 kbp downstream of a paternally expressed known imprinted gene, Plagl1. Phactr2 is transcribed in the opposite direction to Plagl1, which could be another reciprocally-imprinted sense-antisense pair .
Among the seven novel candidates tested, two other genes, Zfp64 and Htra3 have also been verified to be partially imprinted in the mouse placenta. Zfp64 is on mouse chromosome 2, 6 Mbps from a known imprinted gene Nesp. Zfp64 is a Krüppel family transcription factor that is under the control of Runx2, and participates in Notch signalling to regulate differentiation in mesenchymal cells (SAKAMOTO et al. 2008) . Htra3 is a serine protease whose activity is absolutely required for its activity in TGF-beta signalling inhibition (TOCHARUS et al. 2004) . Htra3 was initially discovered to have a strong 100%:0% allelic bias, but the verification results showed only partial imprinting (with a 75%:25% allelic bias). This could be due to the low expression level of Htra3 in the mouse placenta (RPKM < 1).
Finally, considering the last two imprinting validation tests, the pyrosequencing signal from Trim23 was too low to determine the allelic expression percentage. Therefore we could neither confirm nor exclude the imprinting status of Trim23. Gpsm2 was shown in our pyrosequencing assay to be not imprinted in the mouse placenta (Table 2) . Overall the empirical verification rate is quite high (8 out of 9 successful tests), compared to other recently published transcriptome-wide surveys.
Assessment of the degree of maternal contamination in our placenta samples: One caution about identifying novel imprinted genes in the mouse and human placenta is maternal contamination (PROUDHON and BOURC'HIS 2010) . The placenta is a complex organ that consists of many different tissue and cell types. For term and near-term placenta, the contact of maternal and fetal tissues at the interface is challenging to separate by dissection, resulting in the potential for maternal contamination (PROUDHON and BOURC'HIS 2010) . In some studies of novel imprinted genes in the placenta, the possibility for maternal contamination cannot be excluded.
Several approaches were used to minimize maternal contamination in our samples. The first was to take special precautions during the dissection. From every sample collected, tissue was only taken from the middle of the placenta and only from what was clearly the fetal side. Then we washed the tissue multiple times in PBS to remove maternal blood. Second, we quantified the degree of contamination and chose the samples for RNA-seq that had the least maternal contamination (based on allelic expression ratio of several known imprinted genes with 100% paternal expression in placenta). If there were maternal contamination, paternally expressed imprinted genes would display expression from the maternal allele, and the degree of leakage could be used as a criterion to select the best samples. Third, several uterus samples near the placenta were collected at the same time, which allowed us to check the uterus expression level of a gene to determine the potential for contamination. Fourth, with the transcriptome-wide allelic expression profile, maternal contamination would be reflected by an allelic bias throughout the genome. By quantifying read counts of maternal alleles transcriptome-wide, it has been possible to estimate the degree of maternal contamination, and use this estimate to normalize SNP counts in the candidate imprinted genes.
Before we quantify the maternal bias introduced by maternal tissue contamination, we need to understand what other factors could also contribute to the deviation from 50:50 expression ratio of the two parental alleles. First, there is the possibility of global eQTL effects. As we observed from the allelic expression from a single gene, not all genes show 50:50 ratios. If the AKR allele is associated with a cis-regulatory element, it could have higher expression from AKR allele in both reciprocal crosses. If we sum the SNP counts over all genes, it should be close to 50:50. Second, since we are aligning reads with both the AKR and PWD sequences to the B6 reference genome, there will be a mapping bias toward the AKR allele, because the mouse strain genealogy shows that the AKR strain is closer to the B6 strain. So it was important to quantify and remove the mapping bias before we could assess the degree of maternal contamination (See Materials and Methods).
Finally, imprinted X inactivation takes place in the mouse placenta, which means that the X-linked genes in females will be primarily expressed from the maternal allele (SADO and FERGUSON-SMITH 2005) . If a gene/SNP has X chromosome homology, the reads might actually be from the X chromosome, which would create a spurious maternal bias. Consequently, in this analysis the X chromosomal genes were not assessed for imprinting status.
To illustrate these confounding factors for the deviation from 50:50 allelic expression, we present an example in Table 3 . Under a null model, if there is not any global eQTL effect or maternal bias or mapping bias, the allelic expression ratio will be 50:50 in both AKR x PWD and PWD x AKR crosses. Suppose there is 5% mapping bias. We would then always observe 55% expression from the AKR allele in both reciprocal crosses. If there is 5% maternal contamination, we would detect 55% expression of the AKR allele in the AKR x PWD cross, because AKR is the mother in this cross, but 45% expression of the AKR allele in the PWD x AKR cross because PWD is the mother (Table 3) . To quantify the degree of maternal contamination, we compute (p 1_overall -p 2_overall )/2 as an metric whose expectation is zero if there is no maternal contamination (where p 1_overall is the total AKR allelic expression percentage from the AKR x PWD cross summing over all genes in the transcriptome, and p 2_overall is the total AKR expression percentage from the PWD x AKR cross, again summing over the transcriptome). With this metric, eQTL effects will be cancelled out, leaving a bias for un-imprinted genes only if there is maternal contamination.
In our placenta data, the total AKR allelic percentages are 51.99% and 51.52% in the AKR x PWD and PWD x AKR crosses respectively, before correcting the alignment bias (Table 3) . After the mapping bias correction, the percentages are 50.50% and 50.17%, indicating that there is roughly a 1.5% mapping bias (Table 3 ). The maternal contamination is estimated to be 0.15% (Table 3) , a quite tolerably low figure. For genes with moderate and high expression levels in our placenta samples, the effect of maternal contamination was negligible.
Maternally expressed placenta-only imprinted genes: artifacts of maternal contamination?
Because of the maternal contamination problem, the imprinting status has been questioned for 13 placenta-only known imprinted genes (PROUDHON and BOURC'HIS 2010). All are known to be maternally expressed imprinted genes. Among these genes, Gatm, Pon3, Th, Tspan32, Cd81, Tssc4, Tnfrsf23 and Osbpl5 have sufficient SNP coverage in our data to determine the imprinting status with confidence (Table 4 ). The genes, Tfpi2, Pon2 and Dcn, do not show significant parent-of-origin effect in our data, suggesting that they may not be imprinted, at least at stage E17.5 in the AKR-PWD strain combination (Table 4) . Ppp1r9a is detected to be imprinted with preferential maternal expression. Nap1l4 is discovered to be a maternally expressed imprinted gene in the placenta (ENGEMANN et al. 2000) . Others have suggested that there may be leaky expression from the paternal allele (UMLAUF et al. 2004 ). When we examined this gene in detail, we found four SNPs in the gene region, two in the exons and two in the introns. One exonic SNP shows biallelic expression, and the other one shows preferentially maternal expression (Table S3 ). The parent-of-origin effect is not significant if we sum over the two SNPs (Table 4 ). There are also two SNPs covered by the Illumina reads in the intron, with preferential paternal expression (Table S3 ).
This gene maybe imprinted and there might be antisense non-coding transcript in the intronic region, or there may be complications from alternative splice products. Further investigation is needed to determine the imprinting status of Nap1l4.
Maternal contamination could not only create false positive calls for maternally expressed imprinted genes, but also may result in a paternally expressed imprinted gene to be a false negative.
Zdbf2 could be one of such example. Zdbf2 is detected in our data to be imprinted with preferential paternal expression, but it has been previously reported to be biallelically expressed in the placenta (KOBAYASHI et al. 2009 ). However, this could also be due to a different imprinting status of the same gene in different developmental stages/mouse strain combinations.
Is there a bias toward more maternally expressed imprinted genes in the placenta?
Contrasting patterns of genomic imprinting in the brain and placenta raises a series of questions about the mechanism and evolution of the control of imprinting. Previously, in a literature review of the tissue specificity and maternal vs. paternal expression of imprinted genes (MORISON et al. 2005) , it was noted that there is a paternal-brain/maternal placenta bias (PROUDHON and BOURC'HIS 2010; WANG et al. 2008) . The genes imprinted in the brain but not the placenta tend to be paternally expressed, whereas the genes imprinted in the placenta but not the brain tend to be maternally expressed ( Figure 3A and Table S4 , P-value = 0.0001322, Fisher's exact test). Our previous study also provided some suggestive evidence that the brain-paternal bias might be real . Here, we would like to ask whether the maternal-placenta bias is also true, or whether there might be an artifact due to the potential maternal contamination or limited sampling. We covered 35 known imprinted genes and verified five additional novel imprinted genes in this study. If we break them down by the direction of imprinting, we do not see a bias toward more maternally expressed genes ( Figure 3B , P-value = 0.6821, one-sided exact binomial test). If we examine all 251 candidates and classify them by their expression bias, we still see roughly equal numbers of paternally and maternally expressed candidates ( Figure 3C) , and the degree of allelic bias is statistically homogeneous between the two sets of reciprocal offspring.
DISCUSSION
The number of imprinted genes in the mouse genome: Different studies present quite a wide range of estimates of the number of imprinted genes in the mouse genome, ranging from 100 genes (LUEDI et al. 2007) , to 600 genes (LUEDI et al. 2005) , to 1,300 genes (GREGG et al. 2010b) , to 2,000 genes (NIKAIDO et al. 2003) . There are several reasons for the broad range of these estimates.
First, different studies used widely varying approaches, so they will have different false positive rates as well as different coverage and sensitivity. Second, different studies examined different tissues and developmental stages. In our study, we found 251 candidate imprinted genes in the E17.5 placenta falling in the set with a statistical false discovery rate of 0.01, but we also show empirically that the false discovery rate is more like 11%. Most of the top genes in the list are already known to be imprinted, indicating that the genomic imprinting community has done a commendable job of identification of the imprinted genes. Exhaustive enumeration of imprinted genes will require a large community-wide effort, including multiple replicates from multiple lines, with samples of different tissues and developmental time points. If the results are to be interpreted with confidence based on RNA-seq data alone, a blocked and replicated design is essential (AUER and DOERGE 2010).
Our intention here was to apply RNA-seq in a simple, unreplicated design to serve as a means of nominating candidates for subsequent validation. Among our candidate imprinted genes, we selected ten for validation with biological replication and an independent assay for allelespecific expression. One pyrosequencing assay failed, but of the remaining nine, eight of the imprinting candidate genes were soundly confirmed. The candidates were chosen from a list with a theoretical false discovery rate of 0.01, whereas we observed that 1/9, or 11% of the candidates were false discoveries. The discrepancy between the q-value and the true verification rate could arise from several causes, most of which are expected to inflate the false positive rate of an unreplicated RNA-seq study. First, for lowly expressed genes, with only a few mRNA copies in the transcriptome, there is a chance during library construction that only one of the two alleles might be randomly ligated to the adapter and included in the final pool. After sequencing, the gene would resemble a monoallelically expressed gene, when in fact it is not. This is different from the random monoallelic expression that has been reported previously (GIMELBRANT et al. 2007; LOMVARDAS et al. 2006) , where single cells appear to fail to express both alleles. In applying quantitative RNAseq for allele-specific expression, it is critical to assure that high library complexity is attained in order to avoid this allelic dropout caused by an insufficiently complex library. We might not get conclusive results for lowly expressed genes, so we need other independent methods to verify candidates with low expression levels. Second, sequencing bias and mis-alignments could also be a source of discordance. For the statistical test and subsequent inference of a q-value, several assumptions producing ideal experimental conditions are made: there is no sequencing bias, no misalignments, and the SNP-containing read counts are in proportion to the allelic expression ratio.
However, in practice, these assumptions are easily violated. As a result, SNPs that truly have technical problems will be among the candidates that are found to be statistically significant by the Storer-Kim test, and these will be false positive calls. This is another reason why we need independent verification using an orthogonal technology like pyrosequencing. To account for these factors, we used more stringent filters. With our criterion 3 (defined as RPKM>3 and SNP coverage>20), only 113 significant candidates were left. Among the 113 genes, most of the known ones (23/35) and the confirmed novel ones (4/5) are preserved. Thus, by applying expression level and SNP coverage cut-offs, the degree of library complexity and SNP bias problems will be reduced, resulting in a lower false discovery rate. We will reach the theoretical FDR only if we completely remove these effects and meet all the ideal experimental conditions, and the most obvious way to improve the situation is by replication. But it is important to note that even with only a single replicate of RNA-seq runs from each cross, valid, verifiable novel imprinted genes were discovered.
Many pairs of known imprinting genes occur as overlapping sense-antisense pairs (MORISON et al. 2005; WANG et al. 2008) . With a double-strand cDNA RNA-seq library, the allelic expression from the sense vs. antisense transcripts cannot be distinguished, so SNPs that fall in regions where both strands are transcribed may produce false negative calls. By closely examining the SNPs within the candidates, we found some problematic genes with inconsistent SNPs or overlapping sense-antisense gene models. This could also contribute to the low verification rate. In the future, methods that allow preparation of strand-specific RNA-seq libraries should solve this problem (LEVIN et al. 2010) .
Given the various limitations of RNA-seq studies, we conclude that an independent verification such as pyrosequencing or other allele-specific methods is necessary to confirm the imprinting status. It is also important to examine biological replicates, ideally from individuals from different strains to test the possibility of strain-specific effects. A much larger study, with a wellreplicated and blocked design of multiple RNA-seq runs (AUER and DOERGE 2010) would be needed to generate a definitive count of the number of imprinted genes. From our data, ~4.5% (251) of the 5,527 genes having sufficient data to perform the test exhibit significant imprinting in the placenta. Given the empirical FDR of 11% for this test, 224 genes are expected to be verified.
However, the 11% false positive rate was seen among the subset of genes with the lowest q-values, and if all 251 genes were tested, it would likely be higher. On the other hand, the gene list of 251 was generated using strict selection criteria (RPKM >1, p 1 > 0.65 or p 1 <0.35), and the un-measured false negative rate will be inflated. Therefore, while the experiment produces an estimate of 224 imprinted genes, the uncertainty in false positive and false negative rates suggest that a range of 100-250 genes may be the most supportable. Because this study was restricted to the E17.5 placental tissue in AKR-PWD crosses, the true number of imprinted genes across all tissues and stages is likely to be larger.
Artifacts in novel imprinted gene identification:
There are various sources of artifacts in the identification of imprinted genes (PROUDHON and BOURC'HIS 2010) . First, there may be random monoallelic expression instead of genomic imprinting. We verified our candidates in multiple individuals to exclude this possibility. Second, the allelic bias could be generated by an eQTL effect. In our study, we used reciprocal F1s, allowing us to distinguish parent-of-origin effects from the eQTL effects. Third, there may be a strain-specific PCR bias. Random primers were used in the Illumina library preparation, making PCR bias unlikely, and our confirmation method using pyrosequencing did not employ the same PCR primers. The fourth class of artifact is maternal contamination in the dissected placenta tissues. We took pains to avoid and to quantify the maternal contamination in our samples, and our quantitative analysis demonstrates that these efforts were successful (Table 3) . Another artifact that might spuriously lead to allelic bias is homology to the X chromosome. Males inherit the X chromosome from the mother, so the X-linked genes in males will have 100% maternal expression. In female mouse embryos and placental tissues of fetal origin, there is imprinted X inactivation, resulting in preferential expression from the maternal allele. If an autosomal gene/SNP has X homology, there could be non-specific amplification during RT-PCR or mis-alignment for the RNA-seq. Either case would result in spurious identification of a maternally expressed imprinted gene. This could happen even with zero maternal contamination. Careful attention to this possibility during read-mapping should minimize its impact, although it is hard to exclude the possibility entirely.
Is there a paternal-brain and maternal-placenta bias? Previous literature indicates that
there is a maternal bias to allelic expression of imprinted genes in the placenta (MORISON et al. 2005; PROUDHON and BOURC'HIS 2010) . This could be real, or it may be due to over-estimation of maternally expressed imprinted genes due to maternal contamination or under-estimation of the paternally expressed imprinted genes. From our results, we did not observe any bias toward maternally expressed imprinted genes in the placenta (Figure 3) . We think this is simply because some paternally expressed genes are not known to be imprinted in placenta. In the 12 known imprinted genes identified in our data without prior reports of placenta imprinting, 8 of them are paternally expressed. In the list of novel candidate imprinted genes, we did not find any bias toward maternally expressed genes. This is also consistent with the minimal maternal contamination estimated in our study.
Conclusion:
We have shown that even an unreplicated RNA-seq study can identify a highly informative set of genes showing parent-of-origin allelic expression differences that validated with a quite acceptable rate (89%). This provides an excellent set of candidates for genes showing genomic imprinting, including five novel genes that we validated by pyrosequencing in multiple biological samples. The finding that Phf17 shows strong paternally expressed imprinting is especially intriguing, as this gene is part of a histone H4 transacetylase complex, and may specify a parent-of-origin differential histone acetylation. It is not immediately clear why Pde10a, a cAMP and cGMP phosphodiseterase should be maternally expressed and imprinted in the placenta, but the allelic expression bias is well validated. A larger scale RNA-seq study with this reciprocal cross design, sequencing to greater coverage and using biological replication would also be highly informative, allowing assessment of splice isoform-specific imprinting, sex difference in imprinting, inter-strain variability, and more. Left panel: Allele-specific expression levels for genes on chromosome 7 for both AKR female x PWD male and PWD female x AKR male F1 fetal tissue from the placentas. The x-axis is the allelic expression ratio from the AKR allele (0% to 100%) in the two reciprocal crosses. The y-axis is the physical location along the chromosome. The red bar is drawn according to the AKR allelic expression ratio (p 1 ) in the AKR x PWD cross, and the blue bar is the AKR allelic expression ratio 
